Literature DB >> 21952038

Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions.

Christiane D Wrann1, Tobias Laue, Lena Hübner, Susanne Kuhlmann, Roland Jacobs, Lilia Goudeva, Heike Nave.   

Abstract

Epidemiological studies have indicated that obesity is associated with a higher risk for certain cancers caused by elevated levels of adipocyte-derived hormones. Leptin, one such hormone produced by adipocytes, is a major regulator of metabolism and has also been shown to modulate immunity. However, its role in regulating human natural killer (NK) cell functions is largely unknown. Here, we show that the leptin receptor (Ob-R) is expressed on 5% of NK cells isolated from blood donors, as measured with flow cytometry, and expression of the signal-transducing long form of the leptin receptor Ob-Rb was confirmed with quantitative PCR. The Ob-R+ subpopulation displayed a lower expression of CD16, a cell surface receptor mediating antibody-dependent activation. Short-term stimulation with leptin increased IFNγ secretion, CD69 activation marker expression, and cytotoxic lysis of tumor cells; this was mediated by an improved conjugate forming between NK cells and tumor cells as well as higher expression of tumor necrosis factor-related apoptosis-inducing ligand. On the contrary, long-term incubation with leptin significantly impaired these NK cell immune functions and decreased cell proliferation. In addition, phosphorylation of Jak-2 after leptin stimulation was reduced in peripheral mononuclear blood cells from obese humans compared with normal-weight controls. NK cells represent an immune cell population that is crucial for an effective antitumor response. Here, we show that long-term exposure to leptin, similarly to the situation in obese individuals with elevated serum leptin levels, significantly impairs integral parts of NK cell immune functions, possibly linking leptin to increased cancer susceptibility in obesity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21952038     DOI: 10.1152/ajpendo.00057.2011

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  42 in total

Review 1.  Immunomodulation at epithelial sites by obesity and metabolic disease.

Authors:  Kitty P Cheung; Kristen R Taylor; Julie M Jameson
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

Review 2.  Leptin in the interplay of inflammation, metabolism and immune system disorders.

Authors:  Vanessa Abella; Morena Scotece; Javier Conde; Jesús Pino; Miguel Angel Gonzalez-Gay; Juan J Gómez-Reino; Antonio Mera; Francisca Lago; Rodolfo Gómez; Oreste Gualillo
Journal:  Nat Rev Rheumatol       Date:  2017-01-05       Impact factor: 20.543

Review 3.  Adipokines Regulate the Expression of Tumor-Relevant MicroRNAs.

Authors:  Simon Jasinski-Bergner; Heike Kielstein
Journal:  Obes Facts       Date:  2019-04-18       Impact factor: 3.942

Review 4.  Immune cells and metabolic dysfunction.

Authors:  Ashley Eheim; Dasa Medrikova; Stephan Herzig
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

Review 5.  Emerging role of leptin in rheumatoid arthritis.

Authors:  G Tian; J-N Liang; Z-Y Wang; D Zhou
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

6.  Frontline Science: High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells.

Authors:  Virginia K Clements; Tiha Long; Ramses Long; Chas Figley; Daniel M C Smith; Suzanne Ostrand-Rosenberg
Journal:  J Leukoc Biol       Date:  2018-01-03       Impact factor: 4.962

Review 7.  Cellular defense system gene expression profiling of human whole blood: opportunities to predict health benefits in response to diet.

Authors:  Janice E Drew
Journal:  Adv Nutr       Date:  2012-07-01       Impact factor: 8.701

Review 8.  Tissue-Specific Effects of Leptin on Glucose and Lipid Metabolism.

Authors:  Sandra Pereira; Daemon L Cline; Maria M Glavas; Scott D Covey; Timothy J Kieffer
Journal:  Endocr Rev       Date:  2021-01-28       Impact factor: 19.871

Review 9.  The Weight of Obesity in Immunity from Influenza to COVID-19.

Authors:  Fernanda B Andrade; Ana Gualberto; Camila Rezende; Nathércia Percegoni; Jacy Gameiro; Eugenio D Hottz
Journal:  Front Cell Infect Microbiol       Date:  2021-03-17       Impact factor: 5.293

Review 10.  Natural Killer Cell Dysfunction in Obese Patients with Breast Cancer: A Review of a Triad and Its Implications.

Authors:  Esraa Elaraby; Abdullah Imadeddin Malek; Hanan W Abdullah; Noha Mousaad Elemam; Maha Saber-Ayad; Iman M Talaat
Journal:  J Immunol Res       Date:  2021-06-07       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.